“A Review of the Genetic Variants Affecting Efficacy and Adverse Effects of Standard of Care Treatment in Patients With Chronic Myelogenous Leukemia”. Precision Medicine Communications 2, no. 1 (June 30, 2022): 43–58. Accessed May 8, 2026. https://rootspress.org/journals/index.php/PMC/article/view/45.